The New Jersey-based company plans to add about 70 employees as the expansion not only doubles the site’s capacity, but it adds capabilities, most notably the ability to work on high-toxicity drugs. And it also gives the company the ability to commercially producte drugs for client companies drugs in addition to performing clinical tests.
